|
시장보고서
상품코드
2032320
생체전기의학 시장 보고서 : 유형, 제품 유형, 용도, 최종 용도, 지역별(2026-2034년)Bioelectric Medicine Market Report by Type, Product, Application, End Use, and Region 2026-2034 |
||||||
세계의 생체전기의학 시장 규모는 2025년에 246억 달러에 이르렀습니다. 향후 IMARC Group은 2026-2034년에 걸쳐 CAGR 4.56%를 나타내, 2034년까지 372억 달러에 이를 것으로 예측했습니다.
생체전기의학(electroshootical)은 신경계의 전기적 임펄스나 신호를 이용하는 의료 관련 기기를 말합니다. 이는 분자 의학, 신경과학, 생명공학을 융합하여 질병 치료의 생물학적 과정을 위한 신경 자극 기술을 개발하는 것입니다. 그 구성 요소에는 인공와우, 망막 이식, 통증 완화 장치, 심장 박동기, 척수 자극기, 이식형 제세동기 등이 포함됩니다. 생체전기의학에는 류마티스 관절염, 염증성 장질환, 암, 비만, 당뇨, 천식, 마비, 심혈관질환(CVD) 등 다양한 만성질환의 진단과 치료가 가능한 미세 전자 임플란트가 포함됩니다. 비침습적 및 침습적 접근법을 모두 사용하여 다양한 질병과 장애를 치료할 수 있습니다.
생체전기의학 시장 동향
세계 고령화 진행과 심혈관 및 신경 질환의 발병률 증가는 이 시장 전망을 밝게 하고 있습니다. 생체전기의학에서는 이러한 질환의 치료에 심부 뇌 자극, 미주신경 및 천골 신경 자극, 경피적 전기 신경 자극 장치가 사용되고 있습니다. 이에 따라 부정맥의 유병률이 증가하고 있는 것도 이 시장을 견인하는 요인 중 하나입니다. 부정맥 치료에는 이식형 제세동기나 심박조율기가 사용됩니다. 또한, 파킨슨병, 우울증, 비만과 같은 생활습관으로 인한 질환이 증가함에 따라 심부뇌자극기에 대한 수요가 증가하고 있는 것도 시장 성장을 견인하고 있습니다. 여기에 더해 각 제조업체들은 심장 부정맥의 조기 발견 및 진단을 지원하고 소비자의 미충족 수요를 충족시키는 스마트 제품을 속속 출시하고 있어 시장 성장에 탄력을 받고 있습니다. 또한, 첨단 생체전기의학 승인 건수 증가와 새로운 치료법 및 전기치료에 대한 투자 및 자금 조달 확대가 시장 성장에 긍정적인 영향을 미치고 있습니다. 이 외에도 광범위한 연구개발(R&D) 활동, 의료 인프라의 괄목할만한 성장, 소비자의 지출 능력 향상, 치료 목적의 첨단 의료기기의 존재가 시장 성장을 뒷받침하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 생체전기의학 시장
제6장 시장 분석 : 유형별
제7장 시장 분석 : 제품별
제8장 시장 분석 : 용도별
제9장 시장 분석 : 최종 용도별
제10장 시장 분석 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
제14장 가격 분석
제15장 경쟁 구도
KTH 26.05.15The global bioelectric medicine market size reached USD 24.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 37.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.56% during 2026-2034.
Bioelectric medicine or electroceuticals encompasses medical-related devices that utilize electrical impulses and signaling in the nervous system. It combines molecular medicine, neuroscience, and bioengineering to develop nerve-stimulating technologies for biological processes during the treatment of diseases. It consists of cochlear, retinal implants, relief, cardiac pacemakers, spinal cord stimulators, and implantable defibrillators. Bioelectric medicine includes tiny electronic implants that can diagnose and treat various chronic diseases, such as rheumatoid arthritis, inflammatory bowel disease, cancer, obesity, diabetes, asthma, paralysis, and cardiovascular diseases (CVDs). It can treat a wide range of conditions and disorders using both non-invasive and invasive approaches.
BIOELECTRIC MEDICINE MARKET TRENDS:
The growing geriatric population and the increasing incidences of cardiovascular and neurological disorders across the globe are creating a positive outlook for the market. Bioelectric medicine uses the deep brain, vagus sacral, and transcutaneous electric nerve stimulator to treat these conditions. In line with this, the escalating prevalence of arrhythmia that involves the use of implantable cardioverter-defibrillators and cardiac pacemakers to treat the ailment is acting as another growth-inducing factor. Additionally, the increasing demand for deep brain stimulators owing to the rising instances of Parkinson's disease and lifestyle-induced disorders, such as depression and obesity, is favoring the market growth. Apart from this, manufacturers are launching smart products that help in the early detection and diagnosis of cardiac arrhythmias and cater unmet needs of the consumers, which, in turn, is providing an impetus to the market growth. Moreover, increasing approvals for advanced bioelectric medicine and a rise in investment and funding of new therapies and electroceuticals are positively influencing the market growth. Besides this, extensive research and development (R&D) activities, significant growth in the healthcare infrastructure, increasing expenditure capacities of consumers, and the presence of advanced medical devices for treatment purposes are supporting the market growth.
KEY MARKET SEGMENTATION:
Breakup by Type:
- Implantable Electroceutical Devices
- Non-Invasive Electroceutical Devices
Breakup by Product:
- Implantable Cardioverter Defibrillators
- Cardiac Pacemakers
- Cochlear Implants
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Transcutaneous Electrical Nerve Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Others
Breakup by Application:
- Arrhythmia
- Pain Management
- Sensorineural Hearing Loss
- Parkinson's Disease
- Tremor
- Depression
- Treatment-Resistant Depression
- Epilepsy
- Urinary and Fecal Incontinence
- Others
Breakup by End Use:
- Hospitals
- Research Institutes
- Individual Users
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Biotronik SE & Co KG, Boston Scientific Corporation, Cochlear Limited, electroCore Inc., LivaNova PLC, MED-EL Medical Electronics, Medtronic plc and Sonova Holding AG.
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Bioelectric Medicine Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Implantable Electroceutical Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Non-Invasive Electroceutical Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Product
- 7.1 Implantable Cardioverter Defibrillators
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Cardiac Pacemakers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Cochlear Implants
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Spinal Cord Stimulators
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Deep Brain Stimulators
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Transcutaneous Electrical Nerve Stimulators
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Sacral Nerve Stimulators
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
- 7.8 Vagus Nerve Stimulators
- 7.8.1 Market Trends
- 7.8.2 Market Forecast
- 7.9 Others
- 7.9.1 Market Trends
- 7.9.2 Market Forecast
8 Market Breakup by Application
- 8.1 Arrhythmia
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Pain Management
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Sensorineural Hearing Loss
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Parkinson's Disease
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Tremor
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Depression
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Treatment-Resistant Depression
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
- 8.8 Epilepsy
- 8.8.1 Market Trends
- 8.8.2 Market Forecast
- 8.9 Urinary and Fecal Incontinence
- 8.9.1 Market Trends
- 8.9.2 Market Forecast
- 8.10 Others
- 8.10.1 Market Trends
- 8.10.2 Market Forecast
9 Market Breakup by End Use
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Individual Users
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Biotronik SE & Co KG
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 SWOT Analysis
- 15.3.3 Boston Scientific Corporation
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Cochlear Limited
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 electroCore Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.6 LivaNova PLC
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.7 MED-EL Medical Electronics
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Medtronic plc
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Sonova Holding AG
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.1 Abbott Laboratories
